Kainos Capital Acquires InterHealth Nutraceuticals

BENICIA, Calif. — InterHealth Nutraceuticals, Inc (“InterHealth”), a leading researcher, developer and marketer of branded nutraceutical ingredients, today announced that it has been acquired by Kainos Capital, LLC, a Dallas-based private equity firm with an exclusive focus on the food and consumer sector. The transaction marks an inflection point in InterHealth’s evolution into becoming a global leader in providing functional specialty ingredients to the dietary supplement, functional food and beverage, pet health and cosmeceutical end markets.

“InterHealth’s success has been marked by its unique, high quality ingredients, extensieve research program, outstanding customer service and powerful co-branding strategy that delivers relevant and differentiated concepts to its customers,” commented Paul Dijkstra, CEO of InterHealth. Dijkstra added, “Kainos brings deep experience in the nutritional ingredient sector which will assist InterHealth through its next phase of growth.”

“We believe InterHealth is an outstanding organization, led by a management team with a strong commitment to science-based product development and unwavering quality and customer service,” stated Andrew Rosen, Managing Partner of Kainos Capital.  “InterHealth’s portfolio of branded functional ingredients is supported by strong clinical data and addresses functional end markets that have compelling and enduring growth dynamics,” continued Rosen.

“The partnership with Kainos significantly strengthens our ability to supply existing and new customers and should enable us to aggressively expand our portfolio of speciality branded ingredients through strategic partnerships and acquisitions,” added Dijkstra.

C.W. Downer & Co. acted as financial advisor to InterHealth and Delloitte Corporate Finance acted as financial advisor to Kainos.

About InterHealth Nutraceuticals, Inc.

InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include UC-II® for addressing joint discomfort; Super CitriMax®, a weight loss and satiety ingredient; Meratrim® for weight management; and ChromeMate® and Zychrome® for blood sugar and insulin control. In addition, InterHealth offers LOWAT®, Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit www.interhealthusa.com.

About Kainos

Kainos Capital is a middle market private equity firm with an exclusive focus on the food and consumer sector. The Kainos team has extensive investment and operating experience in the industry, having invested more than $2 billion of equity in more than 40 transactions with a total transaction value in excess of $7 billion. The firm’s strategy is to build a diversified portfolio of growing and strategically relevant food and consumer businesses that trade buyers would like to acquire. For more information, visit Kainos Capital’s website atwww.kainoscapital.com.